Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
Active, not recruiting · NCT05101018 · Registry updated 2025-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, central nervous system disorder, injury, metabolic disease, musculoskeletal system disorder, nervous system disorder, nervous system injury, osteoporosis, spinal cord disorder, spinal cord injury | Active, not recruiting | Phase 4 | 2025-09-17 | NCT05101018 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| James J. Peters Veterans Affairs Medical Center | 13 |
| Kessler Institute for Rehabilitation | 4 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| James J. Peters VA Medical Center | The Bronx | United States | 16 |
| Kessler Institute for Rehabilitation | West Orange | United States | 2 |